Effects of Covid-19 on Patients with Cardiovascular Diseases: A Systematic Review

被引:0
作者
Sharma, Naveen [1 ]
Joshi, Priyanka [2 ]
Gupta, Pawan Kumar [1 ]
Shukla, Parjanya Kumar [3 ]
Archna [1 ]
机构
[1] Amity Univ Madhya Pradesh, Amity Inst Pharm, Gwalior 474005, Madhya Pradesh, India
[2] Shri Ram Coll Pharm, Natl Express Way AB Rd Banmore, Morena, MP, India
[3] Krishnarpit Inst Pharm, Prayagraj 212107, Uttar Pradesh, India
关键词
COVID-19; cardiovascular disease; cardiac troponins; angiotensin converting enzyme-II (ACE-II); IMPACT;
D O I
10.9734/JPRI/2021/v33i53B33689
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim of Object: During the COVID-19 pandemic, the entire world is experiencing a mortality situation; most people are battling against the corona virus, but some individuals have already suffered from cardiovascular problems. For improved patient care, adequate information and comprehension of the relationship between cardiovascular disorders and COVID-19 is required. The dominant clinical manifestations of the corona virus infection are on the respiratory system. In this instance, the acute cardiac injury is the most often reported cardiac abnormality, in which the degree of cardiac output is increased, troponin levels rise, and mostly it is found in about 8% to 12% of patients. The involvement of viral cardiomyocytes and systemic inflammation is the most prevalent mechanism for cardiac damage. The corona virus attaches itself and enters through angiotensin converting enzyme-II. Discussion and Conclusion: Recent articles on COVID-19 have revealed nothing regarding these individuals' cardiac vascular manifestations. This is a critical component of all that has a big influence on COVID-19 patients' cardiovascular systems. To fully comprehend the method and effects, more study is required.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 27 条
[1]  
Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1016/j.jacc.2014.09.017, 10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.10.011]
[2]  
[Anonymous], NAT REV CARDIOL
[3]  
[Anonymous], PRODUCT MONOGRAPH
[4]  
[Anonymous], PRESCRIBING INFORM
[5]   SARS-CoV-2: a potential novel etiology of fulminant myocarditis [J].
Chen, Chen ;
Zhou, Yiwu ;
Wang, Dao Wen .
HERZ, 2020, 45 (03) :230-232
[6]  
Chen D., 2020, HYPOKALEMIA CLIN IMP, DOI [10.1101/2020.02.27.20028530, DOI 10.1101/2020.02.27.20028530]
[7]  
Clerkin KJ, 2020, CIRCULATION
[8]   Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic [J].
Driggin, Elissa ;
Madhavan, Mahesh V. ;
Bikdeli, Behnood ;
Chuich, Taylor ;
Laracy, Justin ;
Biondi-Zoccai, Giuseppe ;
Brown, Tyler S. ;
Nigoghossian, Caroline Der ;
Zidar, David A. ;
Haythe, Jennifer ;
Brodie, Daniel ;
Beckman, Joshua A. ;
Kirtane, Ajay J. ;
Stone, Gregg W. ;
Krumholz, Harlan M. ;
Parikh, Sahil A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (18) :2352-2371
[9]   Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper [J].
Friedrich, Matthias G. ;
Sechtem, Udo ;
Schulz-Menger, Jeanette ;
Holmvang, Godtfred ;
Alakija, Pauline ;
Cooper, Leslie T. ;
White, James A. ;
Abdel-Aty, Hassan ;
Gutberlet, Matthias ;
Prasad, Sanjay ;
Aletras, Anthony ;
Laissy, Jean-Pierre ;
Paterson, Ian ;
Filipchuk, Neil G. ;
Kumar, Andreas ;
Pauschinger, Matthias ;
Liu, Peter .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (17) :1475-1487
[10]   2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [J].
Ibanez, Borja ;
James, Stefan ;
Agewall, Stefan ;
Antunes, Manuel J. ;
Bucciarelli-Ducci, Chiara ;
Bueno, Hector ;
Caforio, Alida L. P. ;
Crea, Filippo ;
Goudevenos, John A. ;
Halvorsen, Sigrun ;
Hindricks, Gerhard ;
Kastrati, Adnan ;
Lenzen, Mattie J. ;
Prescott, Eva ;
Roffi, Marco ;
Valgimigli, Marco ;
Varenhorst, Christoph ;
Vranckx, Pascal ;
Widimsky, Petr .
KARDIOLOGIA POLSKA, 2018, 76 (02) :229-313